CanSino Biologics, Inc. Class H's total assets for Q2 2025 were ¥7.71B, a decrease of -1.48% from the previous quarter. HK:6185 total liabilities were ¥2.80B for the fiscal quarter, a -4.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.